98 related articles for article (PubMed ID: 14563609)
21. Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.
Chung CS; Giess CS; Gombos EC; Frost EP; Yeh ED; Raza S; Birdwell RL
AJR Am J Roentgenol; 2014 Apr; 202(4):922-7. PubMed ID: 24660725
[TBL] [Abstract][Full Text] [Related]
22. Experience with breast cancer, pre-screening perceived susceptibility and the psychological impact of screening.
Absetz P; Aro AR; Sutton SR
Psychooncology; 2003 Jun; 12(4):305-18. PubMed ID: 12748969
[TBL] [Abstract][Full Text] [Related]
23. Experiences of recall after mammography screening--a qualitative study.
Solbjør M; Forsmo S; Skolbekken JA; Sætnan AR
Health Care Women Int; 2011 Nov; 32(11):1009-27. PubMed ID: 21978146
[TBL] [Abstract][Full Text] [Related]
24. Coping, psychopathology, and quality of life in cancer patients under palliative care.
Sorato DB; Osório FL
Palliat Support Care; 2015 Jun; 13(3):517-25. PubMed ID: 24783996
[TBL] [Abstract][Full Text] [Related]
25. Who is not reassured following benign diagnosis of breast symptoms?
Meechan GT; Collins JP; Moss-Morris RE; Petrie KJ
Psychooncology; 2005 Mar; 14(3):239-46. PubMed ID: 15386770
[TBL] [Abstract][Full Text] [Related]
26. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer worry and mammography use by women with and without a family history in a population-based sample.
Andersen MR; Smith R; Meischke H; Bowen D; Urban N
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):314-20. PubMed ID: 12692105
[TBL] [Abstract][Full Text] [Related]
28. Psychological morbidity, sources of stress and coping strategies among undergraduate medical students of Nepal.
Sreeramareddy CT; Shankar PR; Binu VS; Mukhopadhyay C; Ray B; Menezes RG
BMC Med Educ; 2007 Aug; 7():26. PubMed ID: 17678553
[TBL] [Abstract][Full Text] [Related]
29. False-negative rate of combined mammography and ultrasound for women with palpable breast masses.
Chan CH; Coopey SB; Freer PE; Hughes KS
Breast Cancer Res Treat; 2015 Oct; 153(3):699-702. PubMed ID: 26341750
[TBL] [Abstract][Full Text] [Related]
30. Surveillance of probably benign (BI-RADS 3) lesions in mammography: what is the right follow-up protocol?
Buch KA; Qureshi MM; Carpentier B; Cunningham DA; Stone M; Jaffe C; Quinn M; Gonzalez C; LaVoye J; Hines N; Bloch BN
Breast J; 2015; 21(2):168-74. PubMed ID: 25669425
[TBL] [Abstract][Full Text] [Related]
31. Women with false positive screening mammograms: how do they cope?
Olsson P; Armelius K; Nordahl G; Lenner P; Westman G
J Med Screen; 1999; 6(2):89-93. PubMed ID: 10444727
[TBL] [Abstract][Full Text] [Related]
32. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
33. Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study.
Rosenberg SM; Moskowitz CS; Ford JS; Henderson TO; Frazier AL; Diller LR; Hudson MM; Stanton AL; Chou JF; Smith S; Leisenring WM; Mertens AC; Cox CL; Nathan PC; Krull KR; Robison LL; Oeffinger KC
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1699-706. PubMed ID: 26304504
[TBL] [Abstract][Full Text] [Related]
34. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
[TBL] [Abstract][Full Text] [Related]
35. Decreasing women's anxieties after abnormal mammograms: a controlled trial.
Barton MB; Morley DS; Moore S; Allen JD; Kleinman KP; Emmons KM; Fletcher SW
J Natl Cancer Inst; 2004 Apr; 96(7):529-38. PubMed ID: 15069115
[TBL] [Abstract][Full Text] [Related]
36. Mammography adherence and psychological distress among women at risk for breast cancer.
Lerman C; Daly M; Sands C; Balshem A; Lustbader E; Heggan T; Goldstein L; James J; Engstrom P
J Natl Cancer Inst; 1993 Jul; 85(13):1074-80. PubMed ID: 8515494
[TBL] [Abstract][Full Text] [Related]
37. Mammography: influence of departmental practice and women's characteristics on patient satisfaction: comparison of six departments in Norway.
Løken K; Steine S; Laerum E
Qual Health Care; 1998 Sep; 7(3):136-41. PubMed ID: 10185139
[TBL] [Abstract][Full Text] [Related]
38. Compliance with screening mammography and breast sonography of young Asian women.
Tsai HW; Twu NF; Ko CC; Yen MS; Yang MJ; Chao KC; Wen L; Chen CY; Chou YH; Chen YJ
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):89-93. PubMed ID: 21439713
[TBL] [Abstract][Full Text] [Related]
39. Baseline Mammography: What Is It and Why Is It Important? A Cross-Sectional Survey of Women Undergoing Screening Mammography.
Horsley RK; Kling JM; Vegunta S; Lorans R; Temkit H; Patel BK
J Am Coll Radiol; 2019 Feb; 16(2):164-169. PubMed ID: 30219346
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
